ApoE Promotes the Proteolytic Degradation of Aβ

Jiang, Qingguang, Lee, C.Y. Daniel, Mandrekar, Shweta, Wilkinson, Brandy, Cramer, Paige, Zelcer, Noam, Mann, Karen, Lamb, Bruce +9 more·2008·Neuron

Cited by (876)

Items 701–800 of 876

  1. Traumatic brain injury as a precursor to neurodegenerative diseases: Mechanisms linking TBI to Alzheimer’s disease
    Kirti Bamel, Anil Panwar, Mukesh Kumar, Sunil Kumar, Varruchi Sharma, Anil Kumar Sharma · 2025 · Brain Disorders
  2. Cognitive Effects of Simulated Galactic Cosmic Radiation Are Mediated by ApoE Status, Sex, and Environment in APP Knock-In Mice
    Laura Wieg, Jason Ciola, Caroline Wasén, Fidelia Gaba, Brianna R. Colletti, Maren K. Schroeder, Robert G. Hinshaw, Millicent N. Ekwudo, David M. Holtzman, Takashi Saito et al. · 2024 · International Journal of Molecular Sciences
  3. Unraveling APOE4's Role in Alzheimer's Disease: Pathologies and Therapeutic Strategies
    Siddhant Tripathi, Yashika Sharma, Dileep Kumar · 2024 · Current Protein and Peptide Science
  4. Inhibition of Sirt2 Decreases ApoE Secretion in Astrocytes and Microglial Cells
    Yuxin Chen, Chunyu Zhou, Mona Abdelhamid, Cha‐Gyun Jung, Makoto Michikawa · 2023 · The Journal of Biochemistry
  5. The Thiazolidinedione Pioglitazone Increases Cholesterol Biosynthetic Gene Expression in Primary Cortical Neurons by a PPARγ-Independent Mechanism
    Graham D. Cocks, Jonathan I. Wilde, Simon J. Graham, Vicky Bousgouni, David J. Virley, Simon Lovestone, Jill C. Richardson · 2010 · Journal of Alzheimer s Disease
  6. ATP-Binding Cassette, Subfamily A (ABC1), Member 7 (ABCA7)
    James C. Turton, Kevin Morgan · 2013 · Springer eBooks
  7. Bioactive Lipids and the Gut-Brain Axis: Diet as a Modulator of Bioactivity and Diversity of Lipids in the Brain
    Ana Ledo, Bárbara S. Rocha, João A.N. Laranjinha · 2019 · Advances in experimental medicine and biology
  8. The Impact of Apolipoprotein E Allelic Variants on Alzheimer’s Disease
    Ezequiel Serrano, Pablo G. Sanz, Francisco José Barrantes · 2021 · Springer eBooks
  9. Expression of N-Terminal Cysteine Aβ42 and Conjugation to Generate Fluorescent and Biotinylated Aβ42
    Sheng Zhang, Gretchen Guaglianone, Michael A. Morris, Stan Yoo, William J. Howitz, Li Xing, Jian‐Guo Zheng, Hannah Jusuf, Grace Huizar, Jonathan Lin et al. · 2021 · Biochemistry
  10. Pharmacogenetics and Pharmacogenomics Impact on Aspirin Response
    Mohd Aftab Siddiqui, Charul Jain, Afreen Usmani, Abdul Hafeez, Mohammad Khalid, Mohd Mujahid · 2024 · Pharmaceutical science.
  11. The role of immunity and neuroinflammation in genetic predisposition and pathogenesis of Alzheimer’s disease
    Seoyoung Yoon, Yong‐Ku Kim · 2015 · Global Medical Genetics
  12. Lipids and Lipoproteins in Alzheimer’s Disease
    Sophie K. Stukas, Iva Kulić, Shahab Zareyan, Cheryl Lea Wellington · 2015 · InTech eBooks
  13. Key Enzymes and Proteins in Amyloid-Beta Production and Clearance
    C. Santos, I. Cardoso, I. Gonçalves · 2011 · InTech eBooks
  14. Analysis of the Relationship between Estradiol and Follicle-Stimulating Hormone Concentrations and Polymorphisms of Apolipoprotein E and LeptinGenes in Women Post-Menopause
    Aleksandra Rył, A Jasiewicz, Anna Grzywacz, Grażyna Adler, Karolina Skonieczna‐Żydecka, Iwona Rotter, Olimpia Sipak‐Szmigiel, Bogdan Rumianowski, Beata Karakiewicz, Anna Jurczak et al. · 2016 · International Journal of Environmental Research and Public Health
  15. Daily oscillation of cognitive factors is modified in the temporal cortex of an amyloid β(1-42)-induced rat model of Alzheimer’s disease
    Cinthia Daiana Coria-Lucero, Carina Ledezma, Andrea Castro, Silvia M. Delgado, Ana Cecilia Anzulovich, Lorena Navigatore-Fonzo · 2021 · Brain Research Bulletin
  16. Proteostasis disruption and lipid dyshomeostasis in neurodegeneration: exploring common druggable targets across sporadic and monogenic disorders
    Priscila Pereira Sena, Lea Friedrich, Alcibiades E. Villarreal, Florian Fath, Liubovi Sopco, Mar Hernández‐Guillamón, Maria Luiza Saraiva Pereira, Gabrielle B. Britton, Jonasz Jeremiasz Weber, Thorsten Schmidt · 2025 · Frontiers in Molecular Neuroscience
  17. Role of non-neuronal cells in neurorepair: a focus on proteinopathy and neurodegeneration
    Santiago Rodríguez-Carreiro, Maria del Carmen Nogales, David Jiménez-Galán, Sara Carmona-Lorenzo, Alicia Caro-Martín, Elisa Navarro, Noemí Esteras · 2024 · Regenerative medicine reports .
  18. ApoE2 affects insulin signaling in the hippocampus and spatial cognition of aged mice in a sex-dependent manner
    Yu Wang, Hanchen Liu, Yijuan Ye, Wenting Fang, Anlan Lin, Xiaoman Dai, Qinyong Ye, Xiaochun Chen, Jing Zhang · 2025 · Cell Communication and Signaling
  19. Strong Improvement of Apolipoprotein E/Low-Density Lipoprotein Receptor Signals by Telmisartan in Poststroke Spontaneously Hypertensive Stroke Resistant
    Toru Yamashita, Yun Zhai, Tomoko Kurata, Nozomi Hishikawa, Nobutoshi Morimoto, Yasuyuki Ohta, Kentaro Deguchi, Koji Abe · 2014 · Journal of Stroke and Cerebrovascular Diseases
  20. Primate-specific 82-kDa choline acetyltransferase attenuates progression of Alzheimer’s disease-like pathology in the APPNL-G-F knock-in mouse model
    Hadir E. AlQot, Rebecca Jane Rylett · 2024 · Scientific Reports
  21. Apolipoprotein E and Mimetics as Targets and Therapeutics for Alzheimer’s Disease
    Michael Peter Vitek, Fengqiao Li, Carol A. Colton · 2015 · Springer eBooks
  22. Molecular Targeting and Translational Research for New Therapeutic Strategies on Alzheimer's Disease
    Kazuyuki Takata · 2013 · YAKUGAKU ZASSHI
  23. Trial Designs Likely to Meet Valid Long-Term Alzheimer's Disease Progression Effects: Learning from the Past, Preparing for the Future
    Aaron S. Kemp, George Thomas Grossberg, Steven J. Romano, Douglas Lorne Arnold, J. Michael Ryan, Roger Alan Bullock, David L. Streiner · 2009 · International Journal of Alzheimer s Disease
  24. The APOE4 conundrum
    Lev Z. Osherovich · 2009 · Science-Business eXchange
  25. Pathogenesis, modulation, and therapy of Alzheimer’s disease: A perspective on roles of liver-X receptors
    Jasminka Štefulj, Ute Panzenboeck, Patrick R. Hof, Goran Šimić · 2013 · Translational Neuroscience
  26. The ABCA7 transporter, brain lipids and Alzheimer’s disease
    Stephanie J. Soscia, Michael L. Fitzgerald · 2013 · Clinical Lipidology
  27. Vitamin A and Cognitive Impairment
    Patrick Sauvant, Catherine Féart, Julie Sauvant, Véronique Pallet · 2014 · Elsevier eBooks
  28. Statins and Reduction of Oxidative Stress in the Aged Brain
    Tomoko Kurata, Kentaro Deguchi, Shoko Deguchi, Yoshio Ikeda, Koji Abe · 2014 · Elsevier eBooks
  29. Idolizing the clearance of Amyloid-β by microglia
    Nienke M. van Loon, Noam Zelcer · 2016 · Annals of Translational Medicine
  30. Apolipoprotein E interacts with amyloid-β oligomers via positively cooperative multivalent binding
    Swagatha Ghosh, Timir Baran Sil, Sukanta Dolai, Kanchan Garai · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
  31. Liver X and thyroid hormone receptors in neurodegeneration
    Margaret N. Warner, Xiaoyu Song, Jan-Åke Gustafsson · 2024 · Genomic psychiatry :
  32. Astrocytic AEBP1-NPAS3-LIPA pathway coordinates cholesterol homeostasis to regulate Alzheimer’s pathology
    Jialin Wu, Xiaonan Lu, Jienian Zhang, Wang Shuaihan, Zeyuan Lu, Yutong Han, Ruihan Yang, Yiliang Su, Cheng Tan, Dianqiu Huo et al. · 2026 · Cell Reports
  33. Amyloid-β clearance: an astrocytic perspective
    Jiayi Li, Zhongyue Lv, X P Chen, Fan Fu, Kaixia Yang, Guogang Lai, Hao Wu, Guomin Xie · 2026 · Frontiers in Neuroscience
  34. Apolipoprotein E (APOE) Isoforms and Neurobiology of Sporadic Alzheimer’s Disease
    Anita Mollica, Giuseppe Berardino, Antonello Bellomo, Mario Altamura, Francesco Panza, Madia Lozupone · 2024 · Springer eBooks
  35. Donepezil and galanin interactions in an animal model of Alzheimer’s disease
    Jonathan J. Sabbagh · 2020 · Digital Scholarship - UNLV (University of Nevada Reno)
  36. High fat lightens the load
    Craig Nicholson · 2008 · Nature reviews. Neuroscience
  37. Gonadal Steroids do not Affect Apolipoprotein E Expression in Aging Mouse Cerebral Cortex
    Sarika Singh, Mahendra Kumar Thakur · 2010 · Cellular and Molecular Neurobiology
  38. The Contribution of the Amyloid Hypothesis to the Understanding of Alzheimer's Disease: A Critical Overview
    Laura Morelli, George L. Perry, Fabrizio Tagliavini · 2012 · International Journal of Alzheimer s Disease
  39. Circadian Synchronization of Cognitive Functions
    Ana Cecilia Anzulovich · 2015 · Springer eBooks
  40. The Relationship Between Astrocyte-mediated Metabolism of β-Amyloid Protein and Pathogenesis of The Early Stages of Alzheimer′s Disease*
    Lu yi Lin, Shujun Xu, Qinwen Wang · 2012 · PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS
  41. Lipid metabolism in the central nervous system and neurodegenerative diseases
    Hideki Hayashi · 2011 · Folia Pharmacologica Japonica
  42. Alzheimer’s Disease
    Joshua H. K. Tam, Stephen Pasternak · 2017 · Elsevier eBooks
  43. Therapeutic Potential of PPARs in Alzheimer’s Disease
    Aman Babanrao Upaganlawar, Chandrashekhar Devidas Upasani, Stella Amarachi Ihim · 2022 · Springer eBooks
  44. Determining association of rho kinase 1 gene polymorphisms with risk of Alzheimer’s disease: a multicenter pilot study
    Ying Gao, Xia Li, Xiaohong Liu, Qianhua Zhao, Xiangqian Che, Qihao Guo, Ru‐Jing Ren, Gang Wang · 2018 · Annals of Translational Medicine
  45. Clinical Applications of Aspirin
    Karsten Schrör · 2008 · Wiley eBooks
  46. Neuroprotective Effects of Extra‐Virgin Olive Oil and its Components in Alzheimer's Disease
    Alaa H. Abuznait, Hisham Qosa, Loqman A. Mohamed, Yazan S. Batarseh, Amal Kaddoumi · 2017 · Wiley eBooks
  47. Current and Developing Methods for Diagnosing Alzheimer's Disease
    Stephanie Jane Fuller, Nicholas Carrigan, Hamid Reza Sohrabi, Ralph Nigel Martins · 2019 · Wiley eBooks
  48. Unveiling the Genetic Landscape of Basal Ganglia: Implications for Common Brain Disorders
    Shahram Bahrami, Kaja Nordengen, Jaroslav Rokicki, Alexey A. Shadrin, Zillur Rahman, Olav Bjerkehagen Smeland, Piotr Pawel Jaholkowski, Nadine Parker, Pravesh Parekh, Kevin Sean O’Connell et al. · 2023 · medRxiv
  49. Genetic Studies of Alzheimer's Disease
    Elin S. Blom · 2008 · KTH Publication Database DiVA (KTH Royal Institute of Technology)
  50. Role of AMPK in aging and age-related loss of behavioral plasticity in C. elegans
    Caroline C. Escoubas · 2018 · HAL
  51. The effects of two Alzheimer's disease related genes APOE and MAPT in healthy young adults: An attentional blink study
    Jianmin Zeng, Ziyun Gao, Xiong Xiong, Xingrong Hou, Huihui Qin, Yong Liu, Howard Bowman, Craig William Ritchie, John Tiernan O'Brien, Li Su · 2024 · Journal of Alzheimer s Disease
  52. Cerebral perfusion alterations in healthy young adults due to two genetic risk factors of Alzheimer’s disease: APOE and MAPT
    Samuel K. Bennett, Jianmin Zeng, Maria‐Eleni Dounavi, Arshad Majid, Sheharyar Sajjad Baig, Matteo De Marco, Craig William Ritchie, John Tiernan O'Brien, Li Su · 2025 · Journal of Cerebral Blood Flow & Metabolism
  53. Age-related macular degeneration and cerebral amyloid angiopathy have similar pathologies from cholesterol-APOE-amyloid-β-complement mediated inflammation
    W. Sambhariya, Catherine Bowes Rickman, P. A. d’Amore, G. Corradetti, G. S. Hageman, Gareth R. Howell, Olivia J. Marola, H. Phatnani, N. Philp, Debasish Sinha et al. · 2026 · Progress in retinal and eye research
  54. Peptide-based therapeutics in the management of Alzheimer’s disease (AD) and their potential to develop novel strategies
    S. U. Nabi, Iyman Rasool, Andleeb Khan, Abrar Ul Haq, Iqra Hussain, Mosin Saleem Khan, Sabhiya Majid, Summya Rashid, Shahzada Mudasir Rashid, Nouroz Sehar et al. · 2026 · Metabolic Brain Disease
  55. Alteration in oral and non‐oral tissues in ligature‐induced periodontitis mice with the Alzheimer's disease risk factor APOE4
    Ae Ri Kim, Yun‐Jung Yoo, Eun‐Jung Bak · 2026 · European Journal Of Oral Sciences
  56. Prospects for Neural Stem Cell Therapy of Alzheimer Disease
    Thorsten Gorba, Sarah Harper, P. Joseph Mee · 2010 · Stem cell biology and regenerative medicine
  57. Nutrigenética y nutrigenómica
    Gloria Sabater Sales, Juan Sabater Tobella · 2010 · Elsevier eBooks
  58. Apo lipoprotein E4 gene APOE4: An early predictor of Dementia / Alzheimer's disease
    Nelofar Sultana, Abdul Rashid Qureshi, Rukhshan Khurshid, F. I. Shad · 2013 · Scientific Research and Essays
  59. Translationale Forschung in der Geriatrie?
    Leo Cornelius Bollheimer, Dorothee Volkert, Tobias Bertsch, Jürgen Martin Bauer, Jochen Klucken, Cornel Christian Sieber, Reinhard Büttner · 2012 · Zeitschrift für Gerontologie und Geriatrie
  60. Does Ginkgo biloba Extract Exert an Effect on Alzheimer’s Disease Progression?
    Yves Christen · 2009 · Oxidative stress and disease
  61. The Role of Protein S-Nitrosylationin Alzheimer’s Disease and its Treatment
    Junfeng Wang · 2015 · Journal of Pharmaceutics & Pharmacology
  62. HIPPOCAMPAL ASTROCYTES AND ALZHEIMER’S DISEASE
    John K. Young · 2014 · The Journal of Prevention of Alzheimer s Disease
  63. Revisiting the genetics of APOE
    Susana Carmona, Célia Kun‐Rodrigues, José Brás, Rita João Guerreiro · 2017 · UCL Discovery (University College London)
  64. An autopsy case of amyloid β-related angiitis with cognitive impairment, multiple infarcts and subcortical hemorrhage
    Takahiro Watanabe, Shinichiro Ukon, Takako Kihara, Yoshihiro Ide, Shohei Matsuo, Yuka Hayashi, Shuhei Kasama, Hiroo Yoshikawa, Yuki Okano, Chiaki Uchida et al. · 2018 · Human Pathology Case Reports
  65. ApoE: A Risk Factor for Dementia
    Humira Jeelani, Jahangir Nabi, Yasmeena Akhter, Nahida Tabasum, Dil Afroze, Faheem Hyder Pottoo, Fasil Ali · 2022 · Springer eBooks
  66. Psychosocial stress and cannabinoid drugs affect acetylation of α-tubulin (K40) and gene expression in the prefrontal cortex of adult mice
    Jordi Tomàs-Roig, Shyam Sundar Ramasamy, Diana Zbarsky, Ursula Havemann‐Reinecke, Sigrid Hoyer‐Fender · 2022 · PLoS ONE
  67. A fast linkage method for population GWAS cohorts with related individuals
    Gregory J. M. Zajac, Sarah A. Gagliano Taliun, Carlo Sidore, Sarah E. Graham, Bjørn Olav Åsvold, Ben Michael Brumpton, Jonas Bille Nielsen, Wei Zhou, Maiken Elvestad Gabrielsen, Anne Heidi Skogholt et al. · 2023 · Genetic Epidemiology
  68. Impact of previous statin use on first intracerebral hemorrhage in cerebral amyloid angiopathy
    C. Helven, Julien Burel, Margot Vannier, David Maltête, Ozlem Ozkul-Wermester, Capucine Hermary, David Wallon, Lou Grangeon · 2023 · Revue Neurologique
  69. Aging and brain free cholesterol concentration on amyloid‐β peptide accumulation in guinea pigs
    K. Sandy Pang, Hao Peng, Betty P. Li, Binyu Wen, Keumhan Noh, Runyu Xia, Anja Toscan, Sylvia Serson, Paul E. Fraser, Rommel G. Tirona et al. · 2024 · Biopharmaceutics & Drug Disposition
  70. The Role of Astrocytes in the Relationship Between Amyloid-ß Accumulation and Synaptic Dysfunction in Alzheimer’s Disease
    Afsheen Fatima, Arij Daou · 2024 · Journal of Student Research
  71. Functional and Structural MRI in Alzheimer’s Disease: A Multimodal Approach
    Michel J. Grothe, Arun L.W. Bokde, Stefan Johannes Teipel · 2014 · Springer eBooks
  72. LIPID SIGNALING IN BRAIN AGING AND ALZHEIMER'S DISEASE: PHARMACOLOGICALLY TARGETING CHOLESTEROL SYNTHESIS, TRANSPORT AND METABOLISM
    James L. Searcy · 2009 · UKnowledge (University of Kentucky)
  73. APOE in AD
    Tim Fulmer · 2012 · Science-Business eXchange
  74. New Data on Risk Gene for Alzheimer Disease Suggests Different Therapeutic Targets
    Tom Valeo · 2011 · Neurology Today
  75. Mild Cognitive Impairment and Early Dementia
    Benito Pereira Damasceno · 2020 · Springer eBooks
  76. Role of Impaired ABC Transporters in Alzheimer’s Disease
    Mahin Haque, Gulzar Ahmed Rather, Ehraz Mehmood Siddiqui, Sadaf Jahan, Andleeb Khan, Hafiz Antar Makeen, Athanasios T. Alexiou, Ghulam Md Ashraf · 2021 · Springer eBooks
  77. Amyloid-β in Brain Aging and Alzheimer’s Disease
    Hiroki Sasaguri, Takaomi C. Saido · 2022 · Springer eBooks
  78. Regulación de la plasticidad astrocitaria por ibuprofeno y FGF2
    Mathieu P. Lichtenstein · 2011 · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
  79. Developing an Alzheimer’s Disease Therapeutic: Identification and Validation of Signaling Pathways Involved in Small Molecule Induction of Nerve Growth Factor
    Justin B. Davis · 2016
  80. A blood-based signature of cerebrospinal fluid A β 1–42 status
    Benjamin Goudey, Bowen J Fung, Christine Schieber, Alzheimer’s Disease Neuroimaging Initiative, Noel G Faux · 2017 · bioRxiv (Cold Spring Harbor Laboratory)
  81. APOE4 expression confers a mild, persistent reduction in neurovascular function in the visual cortex and hippocampus of awake mice
    Orla Bonnar, Kira Shaw, Dori M. Grijseels, Devin Clarke, Laura Bell, Silvia Anderle, Sarah L. King, Catherine N. Hall · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  82. Current World Literature
    2009 · Current Opinion in Lipidology
  83. APOE4 disrupts the central dogma by arresting neuronal proteome dynamics
    Einar Krogsaeter, Justin McKetney, Lishi Li, Isabelle Liu, Alicia Richards, Vishvak Subramanyam, Keyi Yin, Martin Gordon, Pedro Belio Mairal, Erica J. Stevenson et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  84. The effects of chronic calcium dysregulation on behavioral and pathological features of Alzheimer's disease
    Jonathan J. Sabbagh · 2020 · Digital Scholarship - UNLV (University of Nevada Reno)
  85. Papel de los Liver X Receptors en la activación por IFN-gamma y la proliferación de macrófagos y microglía. Implicaciones en neuroinflamación
    M. A. Moro García · 2012 · TDX (Tesis Doctorals en Xarxa)
  86. The Role of Apolipoprotein E Concentration and Isoform in Amyloid-beta Metabolism In Vivo
    Joseph M. Castellano · 2011 · Open Scholarship Institutional Repository (Washington University in St. Louis)
  87. Recombinant AAV gene therapy and delivery for Alzheimer's disease
    Nikisha Carty · 2009
  88. Brain sterol metabolism : modulating Alzheimer’s disease
    Tim Vanmierlo · 2010
  89. LXR AND AROMATASE KNOCK-OUT MICE: ANIMAL MODELS PROVIDING INSIGHT INTO HUMAN DISEASES
    Hyun‐Jin Kim · 2009 · Figshare
  90. Role of the 39-kDa receptor-associated protein (RAP) in Alzheimer's disease
    Hoang, T · 2012 · UTAS Research Repository
  91. Modulating Amyloid Beta Clearance by Altering Cellular and Whole Brain Apolipoprotein E Metabolism
    Jacob M. Basak · 2014 · Open Scholarship Institutional Repository (Washington University in St. Louis)
  92. Predictive Genetic Testing Using Common Variants: Evidence and Translation
    Deanna Alexis Carere · 2015 · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
  93. Non‐amyloid Approaches To Alzheimer's Disease
    Lone Veng, Mary J. Savage, James C. Barrow, Celina Zerbinatti · 2010 · Wiley eBooks
  94. Multiplexing Techniques in Quantitative Proteomics to Study Disease
    Adam R. Evans · 2015 · D-Scholarship@Pitt (University of Pittsburgh)
  95. Clearing up Aβ
    Charlotte Harrison · 2008 · Nature Reviews Drug Discovery
  96. AD Risk Gene Clears Amyloid Beta in Mouse Model
    Jamie Talan · 2008 · Neurology Today
  97. ABCA1, Apoe and apoA-I As Potential Therapeutic Targets for Treating Alzheimer’s Disease
    Dhananjay Namjoshi, Sophie K. Stukas, Cheryl Lea Wellington · 2011 · Neurodegenerative Disease Management
  98. Characterisation of transgenic mouse models of Alzheimer's disease
    Lindsay Graham · 2011 · OpenGrey (Institut de l'Information Scientifique et Technique)
  99. Association of Electrophoretically Resolved Low Molecular Weight Protein Fractions with Senile Dementia in Elderly People
    Sadia Sabir, Nabila Roohi · 2011 · Pakistan Journal of Zoology
  100. The involvement of degradation pathways and neuron-to-neuron transmission in Alzheimer’s disease
    Lotta Agholme · 2012 · KTH Publication Database DiVA (KTH Royal Institute of Technology)